Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.
Eur Radiol. 2019 Oct;29(10):5655-5663. doi: 10.1007/s00330-019-06040-y. Epub 2019 Mar 15.
To evaluate post-ablation MRI for the detection of incompletely treated spinal osseous metastases (SOM) after cryoablation and to propose a post-ablation imaging classification.
After IRB consent, all patients treated with cryoablation of SOM between 2011 and 2017 having at least 1-year minimum follow-up and a spine MRI within 4 months after cryoablation were retrospectively included. A classification of MRI images into four types was set up. The primary endpoint of our study was to assess the diagnostic performance of the post-ablation MRI. The secondary endpoints were the 1-year complete treatment rate (CTR) and complications.
Fifty-four SOMs in 39 patients were evaluated. Post-ablation MRI was performed with a median delay of 25 days after cryoablation. Images were evaluated by two independent readers according to the pre-established image classification. Sensitivity and specificity for the detection of residual tumor were 77.3% (95%CI = 62.2-88.5) and 85.9% (95%CI = 75.0-93.4), respectively. Types I, II, III, and IV of the classification were associated with a 1-year complete treatment in 100%, 83.3%, 35.7%, and 10% of cases, respectively. The 1-year CTR was 59.3% for all 54 metastases, and 95.8% for metastases measuring less than 25 mm and at least 2 mm or more away from the spinal canal. Two grade 3 and two grade 2 adverse events according to the CTCAE were reported.
MRI after cryoablation is useful for the evaluation of the ablation efficacy. The classification of post-cryoablation MRI provides reliable clues for the prediction of complete treatment at 1 year.
• MRI performed 25 days after cryoablation is useful to evaluate the efficacy. • The proposed classification provides a reliable clue for complete cryoablation. • Percutaneous cryoablation of spinal metastases is highly effective for lesions less than 25 mm in diameter and of at least 2 mm away from the spinal canal.
评估冷冻消融术后脊柱骨转移(SOM)不完全治疗的消融后 MRI 检测,并提出消融后影像学分类。
在获得机构审查委员会同意后,回顾性纳入 2011 年至 2017 年间接受 SOM 冷冻消融治疗、至少随访 1 年、冷冻消融后 4 个月内行脊柱 MRI 的所有患者。建立了 MRI 图像分为四型的分类。本研究的主要终点是评估消融后 MRI 的诊断性能。次要终点是 1 年完全治疗率(CTR)和并发症。
共评估了 39 名患者的 54 个 SOM。冷冻消融后中位延迟 25 天进行消融后 MRI。两名独立的读者根据预先设定的图像分类对图像进行评估。残留肿瘤检测的灵敏度和特异性分别为 77.3%(95%CI=62.2-88.5)和 85.9%(95%CI=75.0-93.4)。分类的 I、II、III 和 IV 型分别与 1 年内 100%、83.3%、35.7%和 10%的病例完全治疗相关。所有 54 个转移瘤的 1 年 CTR 为 59.3%,测量直径小于 25mm 且距离椎管至少 2mm 的转移瘤的 1 年 CTR 为 95.8%。根据 CTCAE 报告了 2 例 3 级和 2 例 2 级不良事件。
冷冻消融后的 MRI 对于评估消融效果是有用的。消融后 MRI 的分类为预测 1 年内完全治疗提供了可靠的线索。
• 冷冻消融后 25 天进行的 MRI 有助于评估疗效。• 提出的分类为完全冷冻消融提供了可靠的线索。• 对于直径小于 25mm 且距离椎管至少 2mm 的病变,经皮冷冻消融治疗脊柱转移瘤非常有效。